NC-503

NC-503 · Bellus Health Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NC-503, covering 2010-08-24 to 2010-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase IIa Proof-of-concept Study of NC-503 in Patients With Type II Diabetes [Phase 2]